Bilal Piperdi, MD, discusses an analysis presented at the 2014 ASCO Annual Meeting that looked at RICTOR amplification to define a subset of patients with lung cancer.
Bilal Piperdi, MD, Associate Professor of Clinical Medicine, Department of Medicine (Oncology), Albert Einstein College of Medicine, director, Lung Cancer Program, Montefiore Einstein Center for Cancer Care, discusses an analysis presented at the 2014 ASCO Annual Meeting that looked atRICTORamplification to define a subset of patients with lung cancer.
Read more about defining subsets and predicting outcomes in lung cancer > >
Ornstein Advises on Starting Dose and Management of Lenvatinib in RCC
April 21st 2024During a Case-Based Roundtable® event, Moshe Ornstein, MD, MA, provided guidance on dosing and toxicity concerns in a patient treated with lenvatinib plus pembrolizumab for advanced renal cell carcinoma.
Read More